Does Platelet-Rich Plasma Therapy in Arthroscopic Rotator Cuff Repair Improve Patient Outcome? by Kennedy, Elan B.
Philadelphia College of Osteopathic Medicine
DigitalCommons@PCOM
PCOM Physician Assistant Studies Student
Scholarship Student Dissertations, Theses and Papers
2013
Does Platelet-Rich Plasma Therapy in Arthroscopic
Rotator Cuff Repair Improve Patient Outcome?
Elan B. Kennedy
Philadelphia College of Osteopathic Medicine, elanke@pcom.edu
Follow this and additional works at: http://digitalcommons.pcom.edu/pa_systematic_reviews
Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, and
the Orthopedics Commons
This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student Dissertations, Theses and Papers at
DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Physician Assistant Studies Student Scholarship by an authorized
administrator of DigitalCommons@PCOM. For more information, please contact library@pcom.edu.
Recommended Citation
Kennedy, Elan B., "Does Platelet-Rich Plasma Therapy in Arthroscopic Rotator Cuff Repair Improve Patient Outcome?" (2013).
PCOM Physician Assistant Studies Student Scholarship. Paper 109.
  
 
 
 
 
 
Does platelet-rich plasma therapy in arthroscopic rotator cuff 
repair improve patient outcome? 
 
 
 
 
 
 
Elan B. Kennedy, PA-S  
A SELECTIVE EVIDENCE BASED MEDICINE REVIEW 
In Partial Fulfillment of the Requirements For  
The Degree of Master of Science 
In 
Health Sciences – Physician Assistant 
 
 
Department of Physician Assistant Studies 
Philadelphia College of Osteopathic Medicine 
Philadelphia, Pennsylvania 
 
 
 
December 14, 2012 
  
 Abstract 
 
Objective: The objective of this selective EBM review is to determine whether or not platelet-
rich plasma therapy (PRP) improves patient outcome in arthroscopic rotator cuff repair. 
 
Study Design: Review of three primary research studies published in the English language in 
2011. 
 
Data sources: Three double blind, randomized, controlled trials analyzing the effect of 
augmentation of rotator cuff repair surgery with PRP therapy were found using PubMed.  
 
Outcomes Measured: Each of the three studies measured the effectiveness of PRP therapy in 
arthroscopic rotator cuff repair, with specific regards to pain improvement after surgery, healing 
time and durability of the repair.  Each patient was measured using the Constant score 
preoperatively and at varying intervals postoperatively from three months up to two years.  The 
Constant score measures pain, limitations of activities of daily living, range of motion and 
strength.  
 
Results: Three randomized controlled trials were included in this review.  The study by Randelli 
found that there was a significant increase in Constant scores for the PRP group at 3 months 
postoperative, but no significant difference was found at 6, 12 and 24 months postoperative.  The 
study by Sánchez Márquez found no significant difference between the Constant Scores of both 
groups at 12 months.  The study by Castricini found that there was no significant difference in 
Constant score at an average of 20.2 months postoperative. 
  
Conclusions:  Based upon analysis of three RCT’s, one study found significant improvement in 
pain and strength at various postoperative intervals, while two additional studies found no 
significant improvement.  The mixed nature of these results identifies the need for further 
investigation into the effectiveness of this treatment method. 
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Introduction:   
Rotator cuff tears are a common reason for visits to medical practitioners in the United 
States.  They can be caused by acute injuries related to falls on an outstretched arm or by pulling 
on the shoulder.  It can also be a chronic injury due to long-term and frequent insults to the joint, 
including repetitive overhead movement and lifting.  Tears are often the result of trauma and 
occur more commonly in the elderly.2  Tendons of the supraspinatus, infraspinatus, teres minor 
and subscapularis muscles form the rotator cuff, which is the basis of stability of the shoulder 
joint.  The most commonly torn tendon is the supraspinatus tendon.  Patients typically present 
with weakness or pain with overhead movement.  Additionally, there may be clinical evidence of 
impingement syndrome, where subacromial inflammation leads to decreased muscle strength, 
pain with overhead movement and nocturnal pain.  This paper evaluates three randomized 
controlled trials (RCTs) investigating whether or not platelet-rich plasma (PRP) therapy 
improves patient outcome in arthroscopic rotator cuff repair. 
The exact pathogenesis of rotator cuff tears is not clearly understood at this point. The 
causes may stem from degeneration, impingement or overload.  It is thought to be a combination 
of intrinsic and extrinsic factors that cause joint injury.1  Extrinsic factors include repetitive 
microtrauma and impingement.  Intrinsic factors include hypovascularity of tendons, as well as 
age related changes including decreased cellular activity and changes in the composition of the 
matrix of the tendon.1   Once injured, it is likely that there is difficulty healing due to poor blood 
supply at the humeral insertion point.  Diagnosis is made based on clinical suspicion with 
supporting radiographic evidence.  The preferred imaging method is magnetic resonance imaging 
(MRI), which can show partial or small rotator cuff tears.  Initial work-up includes a radiograph, 
and if patients are unable to have an MRI performed, ultrasound may be used as an alternative.2 
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In many cases, particularly in partial-tears, the preferred method of treatment is 
conservative.  This includes rest, ice, physical therapy, muscle strengthening and analgesia.  In 
some instances, particularly full-thickness tears, the injury is unlikely to heal without proper 
surgical intervention.  Surgical techniques vary, but may consist of arthroscopic repair with 
reanchoring of the tendons to the tubercle of the humerus.  Surgical techniques have improved 
bone-to-tendon fixation, but the long term re-tear rates and overall tendon degradation are 
common.10    
To improve outcomes, the relatively new technique of augmenting surgical repair with 
the addition of PRP intraoperatively is under investigation.  This technique uses platelet-rich 
plasma, which is a whole blood fraction containing high platelet concentration.  This provides 
the addition of various growth factors, including transforming growth factor beta (TGF-!), 
fibroblast growth factor (FGF), platelet derived growth factor (PDGF), vascular endothelial 
growth factor (VEGF), connective tissue growth factors and epidermal growth factor (EGF). 3 
The proposed benefit of including PRP in surgical rotator cuff repair is that it allows platelet-
derived factors to be locally available to the tissue throughout the healing process.4 
Rotator cuff tears are one of the most common pathologies affecting the shoulder.  
Estimates in prevalence of shoulder pain range from 16 to 34 percent in the general population.5,6 
In the United states there are greater than 4.5 million annual physician visits due to rotator cuff 
tears and greater than 250,000 rotator cuff repairs are performed each year.7  A cadaveric study 
found the incidence of full-thickness rotator cuff tears in subjects older than 60 years to be 30 
percent.3  The cost of an individual surgery has been estimated at between $10,605 and $11,914 
for the physician and hospital services.8 This cost estimate does not include the cost of early re-
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tears which lead to more frequent physician visits, longer rehabilitation time and costly repeat 
rotator cuff surgeries.   
Objective:  
The objective of this selective EBM review is to determine whether or not platelet-rich 
plasma therapy improves patient outcome in arthroscopic rotator cuff repair. 
Methods: 
 The chosen studies were all randomized controlled trials. The populations included were 
patients with rotator cuff tears who had chosen to undergo arthroscopic rotator cuff repair. The 
intervention used in these studies was augmentation of arthroscopic rotator cuff repair with 
intraoperative platelet-rich plasma therapy.  These groups were compared to control groups, 
which included patients receiving arthroscopic rotator cuff repair without PRP therapy.  The 
outcomes measured in these studies were the effectiveness of PRP therapy in arthroscopic rotator 
cuff repair, with specific regards to pain improvement after surgery, healing time and durability 
of the repair.   
 A detailed search was completed utilizing the search engine Pubmed.  The keywords 
“platelet rich plasma” and “rotator cuff” were used in combination to search for English-
language articles. All of the resulting qualified articles were published in 2011 in peer-reviewed 
journals. The included studies must have been randomized, controlled, double blind studies and 
they must have included patient oriented outcomes (POEMs).  The studies also must have 
included patients with complete rotator cuff tears who had failed conservative treatment.  Studies 
were excluded if they had been included in previous systematic reviews or meta-analyses.  
Studies were excluded if patients had previous surgery to the affected shoulder.  Each study had 
its own specific inclusion and exclusion criteria, which are included in table 1.  The continuous 
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data in the studies included the use of p-values, 95% confidence intervals (CI), Student’s t-test, 
the Mann-Whitney U test, unpaired t test and various probabilities.  Because none of the studies 
presented dichotomous data, there were no reported RRR, ARR, and NNT values.  Table 1 
demonstrates the demographics included in the studies. 
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Table 1: Demographics and Characteristics of Included Studies  
 
Study Type # pts Age Inclusion Criteria Exclusion Criteria W/D Interventions 
Randelli3, 
2011 
Double 
blind 
RCT 
45 Mean 
(61.6; 
59.5) 
 
1) A complete 
rotator cuff tear  
2) Brace 4 weeks 
postoperative 
3) platelet count > 
than 150,000 
4) Hgb " 11.0g/dL  
5) No infectious 
disease prior that 
inhibits follow up  
6) Had a BMI # 33 
 
1) Previous rotator 
cuff repair 
2) Active infection, 
osteomyelitis, sepsis 
3) Bone disorders 
4) Uncooperative pt 
5) Disease of shoulder 
6) Smoke cigarettes 
7) Steroid injection in 
affected shoulder. 
 
9 Applying 
intraoperative 
autologous 
platelet-rich 
plasma (PRP) to 
arthroscopic 
rotator cuff repair. 
 
Castricini4, 
2011 
Double 
blind 
RCT 
88 37-72 1) Supraspinatus 
tear 
2) Failed 6 months 
nonoperative tx 
3) No episodes of 
shoulder instability 
4) No signs of fx of 
the glenoid, greater 
or lesser tuberosity 
5) MRI showing 
tear 
6) Repairable full-
thickness tear  
7) injury of long 
head of the biceps 
 
1) Inflammatory joint 
disease 
2) Irreparable tear 
3) Symptomatic 
arthritis of AC joint 
4) Rotator cuff 
arthropathy 
5) Pathologic 
abnormalities of the 
subscapularis tendon 
6) Workers’ 
compensation claims 
7) Prior surgery on the 
affected shoulder 
 
N/A Applying 
intraoperative 
autologous 
platelet-rich fibrin 
matrix (which can 
be sutured in place 
at the site of the 
tear) to 
arthroscopic 
rotator cuff repair.   
 
Sanchez6, 
2011 
Double 
blind 
RCT 
28 53-78 1) Massive rotator 
cuff tear (>5cm) 
2) Supraspinatus 
and infraspinatus 
tendons involved 
3) Conservative tx 
at least 3 months 
 
1) Prev. shoulder sx 
2) Small/subscapular 
tendon tear 
3) Capsulitis 
4) Degenerative 
change 
5) Chronic infectious 
disease 
6) Hgb <13g/dL 
7) Hematological or 
coagulation disorder 
8) h/o difficulty 
cannulating a 
peripheral vessel 
N/A Applying platelet-
rich plasma (PRP) 
with high fibrin 
content in the 
repair area of 
massive rotator 
cuff tears treated 
using arthroscopic 
techniques.   
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Outcomes Measured 
Clinical outcome was measured using the “Constant score”.  The Constant-Murley 
scoring system was used to measure shoulder pain, activities of daily living, range of movement 
and power.  Each of these variables was measured separately and combined to form a total score 
to assess overall patient outcome.  Pain and ADLs were subjectively measured, and range of 
movement and power were objectively measured.  Pain, ADLs, range of movement and power 
were all measured based on the patient’s self-described pain level.  Even while the range of 
movement and power were objectively measured, the measurements were gathered based upon 
the degree to which the patient was able to use their shoulder without experiencing subjective 
pain. 
The Constant score is based on a point total out of a maximum of 100.  Pain is measured 
using the Visual Analog score (VAS) and given a maximum of 15 points if there is a total 
absence of pain.  Limitations of activities of daily living include disturbances in sleep, work and 
recreation, with a maximum of 20 points if there are no limitations.  Range of motion is 
measured and given a maximum score of 40 points if full range of motion is achieved without 
significant pain.  Strength is measured using a dynamometer and given a maximum score of 25 
points.  Strength is measured to the point at which patients experience pain.   
Results 
 The three randomized controlled trials in this review utilized continuous data and could 
not be converted to dichotomous data.  The three studies looked at the use of PRP augmentation 
in arthroscopic rotator cuff repair.  In all studies, the placebo used was arthroscopic rotator cuff 
repair without the use of PRP therapy augmentation.  The type of PRP augmentation and the 
surgical technique varied slightly between studies.  The Randelli et al study used 6ml of 
Kennedy: PRP Therapy and Rotator Cuff Tears 7 
injectable PRP in combination with autologous thrombin component and a surgical technique 
involving a single-row anchor technique with acromioplasty.  The Sánchez Márquez et al study 
used 7ml of injectable fibrin-rich PRP and a surgical technique involving a single-row anchor 
technique.  The Castricini et al study used a suturable membrane of autologous fibrin PRP and a 
surgical technique involving a double-row anchor technique.  The Randelli et al study and the 
Castricini et al study included patients with any complete rotator cuff tears confirmed 
intraoperatively, while the Sánchez Márquez et al study included only patients with a massive 
rotator cuff tear.  In all studies patients were evaluated preoperatively using the Constant-Murley 
score, and they were then evaluated postoperatively at varying time periods.  Patients were also 
evaluated using the Visual Analog scale alone in the immediate postoperative period in the 
Randelli et al study.   
 In the Randelli et al study, there was no significant difference in Constant scores pre-
operative, or at 6, 12 or 24 months.  There was, however, significant difference in Constant 
scores at 3 months post-operative.  The reported values for Constant scores found that pre-
operatively, the PRP group reported a score of 44 ± 16.5 and the control group reported a score 
of 42.2 ± 15.2 (P = .6).  At 3 months post-op, the PRP group reported Constant scores of 65 ± 9 
and the Control group reported scores of 57.8 ± 11 (P = .02).  At 6 months, the PRP group 
reported scores of 73.1 ± 8.7 and the control group reported scores of 72.3  ± 12.6 (P = .7).  At 
12 months the PRP group reported scores of 79.3 ± 6.4 and the control reported 75.7 ± 9.5 (P = 
.3).  At 24 months the PRP group reported scores of 82.4 ± 6.3 and the control group reported 
78.7 ± 10 (P = .1).  Table 2 shows the Constant scores at each of the reported time intervals.  
Table 3 reports the mean change of the Constant values from the pre-operative value to the last 
reported post-operative value. 
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 In the Sánchez Márquez et al study, there was no significant difference in reported 
Constant scores at a pre-operative visit and at 12 months post-operative. The pre-operative 
values were reported as 39.7 ± 10.2 in the PRP group and 34.3 ± 11.7 in the control group (P = 
.79).  At 12 months, the PRP group reported 65.6 ± 13.1 and the control group reported 64.1 ± 
13.6 (P = .79).   Table 2 shows the Constant scores at each of the reported intervals.  Table 3 
reports the mean change of the Constant values from the pre-operative value to the last reported 
post-operative value. 
 In the Castricini et al study, patients were evaluated pre-operatively and again post-
operatively at an average of 20.2 months (range 16-30 months).  There was no significant 
difference in total Constant score between the control and PRP groups.  Pre-operative values 
were reported as a Constant score of 42 ± 6.65 in the PRP group and 42.9 ± 7.92 in the control 
group.  Post-operative follow-up was reported as 88.4 ± 7.62 in the PRP group and 88.4 ± 7.78 in 
the control group (P = .44).  Table 2 shows the Constant scores at each of the reported intervals.  
Table 3 reports the mean change of the Constant values from the pre-operative value to the last 
reported post-operative value. 
Table 2: Platelet-Rich Plasma therapy vs. Control mean values  
Study Pre-op 
Constant score 
(PRP; Control) 
3-month 
Constant score 
(PRP; Control) 
6-month 
Constant score 
(PRP; Control) 
12-month 
Constant score 
(PRP; Control) 
24-month 
Constant score 
(PRP; Control) 
Randelli et 
al, 2011 
44±16.5; 
42.2±15.2  
(P = .6) 
65.0 ± 9.0;  
57.8 ± 11  
(P = .02) 
73.1 ± 8.7;  
72.3  ± 12.6  
(P = .7) 
79.3 ± 6.4;  
75.7 ± 9.5  
(P = .3) 
82.4 ± 6.3;  
78.7 ± 10  
(P = .1) 
Sánchez 
Márquez 
et al, 2011 
39.7 ± 10.2; 
34.3 ± 11.7 
(P = .79) 
NR* NR* 65.6 ± 13.1; 
64.1 ± 13.6 
(P = .79) 
NR* 
Castricini 
et al, 2011 
42 ± 6.65;  
42.9 ± 7.92 
(P=.44) 
 
NR* NR* NR* (Average 20.2 
months post-op) 
88.4 ± 7.62; 88.4 
± 7.78 (P = .44) 
*NR = not reported 
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Table 3: Mean change of Constant score from baseline to final reported value 
 Randelli et al, 2011 
(PRP; Control) 
Sánchez Márquez et al, 2011 
(PRP; Control) 
Castricini et al, 2011 
(PRP; Control) 
Mean change from 
baseline to final 
Constant score 
38.4; 36.5 
(P = .01) 
25.9; 29.8 
(P < .005) 
46.4; 45.5 
(P < .001) 
 
Discussion 
 All three randomized, controlled studies found a high degree of patient satisfaction from 
rotator cuff repair, regardless of the addition of PRP to conventional repair.  Patients’ Constant 
scores significantly improved in all aspects in both arms of each study, the PRP group and the 
control group. 
The study by Randelli et al was a randomized, controlled trial, which found that there 
was a lower pain score observed in the PRP group in the first month after surgery.  A 
multivariate model was used to analyze the Constant scores, which concluded that pain and 
activity scores significantly improved at 3 months postoperative.  Constant scores were higher in 
the PRP group throughout the study, but the difference was not significant at 6, 12 and 24 
months.  The study reports that a potential reason for the lower pain scores observed in 
immediate post-operative period may be due to the analgesic properties of platelets.   
 The study by Sánchez Márquez et al was a randomized, controlled trial, which found that, 
in massive rotator cuff tears, application of PRP during arthroscopic repair does not improve 
functional results and does not reduce the risk of re-tear.  In this study, “the Student’s t-test to 
was used to compare the mean for each group.  When the assumption of normality was not 
accepted, the non-parametric Mann-Whitney U test was used.”9  Results were presented with 
statistical significance being accepted when P<.05.  This study only included patients with 
massive rotator cuff tears.  Patients with massive rotator cuff tears are at very high risk of 
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retearing the tendons, which is why in theory applying PRP during surgery could help with 
patient outcomes.  The results of this small study, however, found no such benefit. 
 In the randomized, controlled trial by Castricini et al, it was found that in small and 
medium rotator cuff tears, augmentation with PRP did not result in significant improvement in 
shoulder function (measured by the Constant score) and structural outcome (evaluated by MRI).  
The statistical analysis was done using the “intention-to-treat” principle.  The distribution of both 
groups’ Constant scores was normal, therefore the study, “used the unpaired t test to compare the 
post-operative results between the 2 groups.”7  95% confidence intervals were then calculated 
and a P value less than .05 was considered significant.  The study also concluded that the use of 
autologous platelet-derived growth factors result in longer surgical time and higher expense.   
Conclusion 
 Based on the studies reviewed, the addition of PRP therapy to conventional arthroscopic 
rotator cuff repair in patients with complete tears appears to be inconclusive.  In all studies, 
patient outcome was significantly improved after having arthroscopic rotator cuff repair, 
regardless of whether or not there was the addition of PRP.  There were no reported adverse 
events due specifically to the PRP therapy, but the cost and increased time in surgery are 
significant and need to be taken into consideration.  Randelli et al found that there was 
improvement in pain scores in the first month after surgery as well as in the Constant scores at 3 
months.  This led to the conclusion that this therapy may be effective in the short term, allowing 
quicker return to activity and work.  The other two studies, Sánchez Márquez et al and Castricini 
et al, did not find any statistically significant improvement in patient outcomes when PRP 
augmentation was used.   
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There were certain shortcomings in each of the trials that could have led to discrepancies 
in the observed outcomes.  One of the most important weaknesses of these trials is their small 
sample size.  There was also a lack of information about the exact numbers of platelets and the 
quantity of growth factors actually delivered to the patients.7  There is currently a widespread 
heterogeneity of collection methods and application techniques of PRP.  In order to improve 
accuracy of trials in the future, a more homogenous method of platelet collection and application 
should be established and studied.  The mixed results of these trials highlights the need for 
further studies to be completed before a definitive conclusion can be reached on the use of PRP 
augmentation in the repair of rotator cuff tears.   
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